InsidersTradesSigma
Explore the full record of transactions filed by Haas Jason, Director. Insider active across 1 company, notably Ligand Pharmaceuticals INC. In total, 1 filings have been recorded. History available since 29 June 2022. The latest transaction was disclosed on 29 June 2022 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
1 of 1 declaration
Jason Haas is a Director of LIGAND PHARMACEUTICALS INC. He plays a key role in the governance of the company by contributing to strategic decision-making. His experience in the pharmaceutical sector allows him to make significant contributions to board discussions.